#Pharmaceutical-Industry
Events indexed under #Pharmaceutical-Industry — 34 entries in the record.
Activity over time
Events per year
| Date | Event | Lanes | Status |
|---|---|---|---|
| 2026-02-18 | FDA Commissioner Makary and Deputy Prasad Announce End of Two-Trial Drug Approval Standard in NEJM — Most Significant FDA Safety Change Since 1962 Food and Drug Administration · Marty Makary · Vinay Prasad · Donald Trump | confirmed | |
| 2025-11-06 | Trump Announces Weight Loss Drug Price Deals With Eli Lilly and Novo Nordisk Donald Trump · Eli Lilly · Novo Nordisk · U.S. Department of Health and Human Services | reported | |
| 2025-01-15 | Patrizia Cavazzoni's FDA to Pfizer Move Epitomizes Regulatory Capture Patrizia Cavazzoni · Food and Drug Administration · Pfizer · Robert F. Kennedy Jr. · +3 | confirmed | |
| 2024-12-31 | Healthcare Industry Spends Record $744 Million on Federal Lobbying in 2024, Pharmaceutical Sector Leads at $384 Million PhRMA · American Medical Association · American Hospital Association · Pharmaceutical Care Management Association · +2 | confirmed | |
| 2024-09-20 | FDA Commissioner Califf's Pharmaceutical Industry Revolving Door Scrutinized Robert Califf · Food and Drug Administration · Verily Life Sciences · Joe Manchin · +1 | confirmed | |
| 2024-06-27 | Supreme Court Rejects $6B Purdue Pharma Settlement Granting Sackler Family Immunity from Opioid Lawsuits U.S. Supreme Court · Sackler Family · Purdue Pharma · Department of Justice | confirmed | |
| 2023-01-01 | Cancer Drug Shortage Crisis Enables Gray Market Profiteering - Carboplatin Price Jumps from $50 to $500 Per Vial Big Pharma · Teva Pharmaceuticals · Food and Drug Administration · Gray Market Vendors · +1 | confirmed | |
| 2022-03-15 | FDA Commissioner Confirmed Amid Pharmaceutical Industry Ties Controversy Robert Califf · United States Senate · FDA Leadership · Pharmaceutical Industry Executives | confirmed | |
| 2021-10-01 | Former FDA Commissioner Stephen Hahn Joins Moderna Backer Flagship Pioneering Stephen Hahn · Flagship Pioneering · Moderna · Food and Drug Administration · +2 | confirmed | |
| 2020-05-08 | AbbVie Completes $63 Billion Allergan Acquisition: Pharmaceutical Industry Consolidates Into Oligopoly AbbVie · Allergan · Federal Trade Commission | confirmed | |
| 2019-11-15 | Bristol-Myers Squibb Completes $74 Billion Celgene Acquisition Despite FTC Concerns Bristol-Myers Squibb · Celgene · Federal Trade Commission · Amgen · +1 | confirmed | |
| 2018-10-16 | AbbVie Humira Patent Thicket Delays US Biosimilars Until 2023 Despite 2016 Patent Expiration and European Competition AbbVie · Amgen · Samsung Bioepis · Mylan · +4 | confirmed | |
| 2018-01-24 | Alex Azar Confirmed as HHS Secretary After Doubling Insulin Prices at Eli Lilly Alex Azar · Eli Lilly · U.S. Department of Health and Human Services · Ron Wyden · +1 | confirmed | |
| 2015-11-19 | Johns Hopkins Study Exposes Orphan Drug Act Gaming - Seven of Top 10 Drugs Exploiting Tax Breaks for Rare Diseases Johns Hopkins University · Food and Drug Administration · AbbVie · Roche · +5 | confirmed | |
| 2015-10-31 | Valeant Pharmaceuticals Scandal Exposes Systematic Price Gouging Strategy - 3000% Increase on Syprine, Philidor Fraud Network Valeant Pharmaceuticals · J. Michael Pearson · Philidor Rx Services · William Ackman · +3 | confirmed | |
| 2014-06-01 | FDA Statistician Joan Buenconsejo Joins AstraZeneca After Overseeing Company Drug Reviews Joan Buenconsejo · Food and Drug Administration · AstraZeneca · Center for Drug Evaluation and Research | confirmed | |
| 2013-06-17 | Supreme Court Allows Antitrust Challenge to Pay-for-Delay Drug Settlements Costing Consumers $3.5 Billion Annually Supreme Court of the United States · Federal Trade Commission · Solvay Pharmaceuticals · Actavis · +2 | confirmed | |
| 2012-12-05 | ACA Architect Liz Fowler Leaves White House for Johnson & Johnson After Industry-Friendly Healthcare Legislation Elizabeth Fowler · Johnson & Johnson · WellPoint · Max Baucus · +2 | confirmed | |
| 2012-09-01 | New England Compounding Center Fungal Meningitis Outbreak Kills 64, Sickens 798 - FDA and State Regulators Ignored Decade of Violations New England Compounding Center · Barry Cadden · Food and Drug Administration · Massachusetts Board of Pharmacy · +2 | confirmed | |
| 2010-12-15 | FDA Arthritis Drug Reviewer Jeffrey Siegel Joins Genentech After Approving Company Tocilizumab Jeffrey Siegel · Food and Drug Administration · Genentech · Roche · +1 | confirmed | |
| 2010-04-05 | Purdue Reformulates OxyContin as "Abuse-Deterrent" After 14 Years, Drives Users to Heroin Purdue Pharma · Food and Drug Administration · Sackler Family | confirmed | |
| 2009-06-01 | Obama Cuts $80B PhRMA Deal Abandoning Medicare Negotiation Promise Barack Obama · PhRMA · Billy Tauzin · Jim Messina · +2 | confirmed | |
| 2009-01-01 | Energy and Commerce Committee Members Receive $45M From Pharma During ACA Debate House Energy and Commerce Committee · Fred Upton · PhRMA · Pfizer · +1 | confirmed | |
| 2007-08-27 | Questcor Raises Acthar Gel Price from $1,600 to $23,000 Overnight - Eventually Reaching 97,000% Increase Through Bribery Scheme Questcor Pharmaceuticals · Mallinckrodt · Federal Trade Commission · Humana · +2 | confirmed | |
| 2004-09-30 | Merck Withdraws Vioxx After Concealing Heart Attack Risk, FDA Failure Causes Estimated 28,000-55,000 Deaths Merck · Food and Drug Administration · David Graham · Raymond Gilmartin | confirmed | |
| 2003-11-25 | Medicare Part D Passes After Pharmaceutical Industry Writes Price Negotiation Ban Billy Tauzin · House Energy and Commerce Committee · PhRMA · Medicare | confirmed | |
| 2002-01-01 | Insulin Prices Begin Tripling 2002-2013 as Three Manufacturers Control 99% of Market - From $231 to $762 Annually Eli Lilly · Novo Nordisk · Sanofi · Congressional Diabetes Caucus · +1 | confirmed | |
| 2001-01-01 | Purdue Pharma Bonus System Incentivizes Sales Reps to Target Highest Opioid Prescribers Purdue Pharma · Sackler Family | confirmed | |
| 1997-11-21 | FDA Modernization Act Accelerates Drug Approvals and Expands Direct-to-Consumer Advertising Under Pharma Pressure Bill Clinton · PhRMA · Food and Drug Administration · James Jeffords | confirmed | |
| 1996-01-01 | Purdue Pharma Launches Aggressive OxyContin Marketing Campaign Based on False Claims Purdue Pharma · Sackler Family · Richard Sackler | confirmed | |
| 1995-12-12 | FDA Approval of OxyContin Reveals Systemic Regulatory Capture by Purdue Pharma Curtis Wright IV · Purdue Pharma · Food and Drug Administration · Division of Anesthetic, Critical Care, and Addiction Drug Products · +1 | confirmed | |
| 1992-10-29 | FDA Prescription Drug User Fee Act Creates Financial Dependence on Pharmaceutical Industry Food and Drug Administration · PhRMA · U.S. Congress · Pharmaceutical companies | confirmed | |
| 1984-09-24 | Hatch-Waxman Act Grants Pharma Patent Extensions While Creating Loopholes to Block Generics Orrin Hatch · Henry Waxman · Ronald Reagan · PhRMA | confirmed | |
| 1962-10-10 | Thalidomide Scandal Drives Kefauver-Harris Amendment Strengthening FDA Drug Safety Requirements Senator Estes Kefauver · Representative Oren Harris · President John F. Kennedy · Frances Kelsey · +2 | confirmed |